Last edition
News about "Vanderbilt University Medical Center"
LG AI Research Partners with D&D Pharmatech for Oral Peptide Drug Discovery
LG AI Research and D&D Pharmatech have partnered to accelerate next-generation oral peptide drug discovery using advanced AI technologies. The collaboration aims to enhance drug development efficiency and strengthen LG’s leadership in the rapidly growing AI-driven biopharmaceutical market.
Vanderbilt University Medical Center | 18/06/2026 | By News Bureau
Avobis Bio’s lead therapeutic, AVB-114, has received FDA’s RMAT designation for Crohn’s perianal fistulas, building on its Fast Track status to accelerate development with enhanced regulatory support and guidance.
Vanderbilt University Medical Center | 06/10/2025 | By Dineshwori | 303
Standigm and Nashville Biosciences join to revolutionize early drug discovery
Standigm and Nashville Biosciences join to revolutionize early drug discovery
Vanderbilt University Medical Center | 14/08/2023 | By Sudeep Soparkar | 858
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy